Sun Life Reports Second Quarter 2022 Results
|
|
- Q2'22 reported net income of
$785 million decreased 13% and underlying net income(1) of$892 million increased 1% from Q2'21. - Q2'22 reported EPS(2) was
$1.34 and underlying EPS(1)(2) was$1.52 . - Q2'22 reported ROE(1) was 13.1% and underlying ROE(1) was 14.9%.
"Sun Life's second quarter results reflect the strength and resilience of our diversified business mix in the face of market volatility and a challenging external environment," said
"We're helping our Clients achieve lifetime financial security and live healthier lives through several strategic initiatives. In the
|
Quarterly results |
Year-to-date |
||||
|
Profitability |
Q2'22 |
Q2'21 |
2022 |
2021 |
|
|
Reported net income - Common shareholders ($ millions) |
785 |
900 |
1,643 |
1,837 |
|
|
Underlying net income ($ millions)(1) |
892 |
883 |
1,735 |
1,733 |
|
|
Reported EPS ($)(2) |
1.34 |
1.53 |
2.80 |
3.12 |
|
|
Underlying EPS ($)(1)(2) |
1.52 |
1.50 |
2.97 |
2.95 |
|
|
Reported return on equity ("ROE")(1) |
13.1 % |
16.3 % |
13.7 % |
16.5 % |
|
|
Underlying ROE(1) |
14.9 % |
16.0 % |
14.5 % |
15.5 % |
|
|
Growth |
Q2'22 |
Q2'21 |
2022 |
2021 |
|
|
Insurance sales ($ millions)(1) |
736 |
710 |
1,535 |
1,440 |
|
|
Wealth sales and asset management gross flows ($ millions)(1) |
57,376 |
55,013 |
115,263 |
120,975 |
|
|
Value of new business ("VNB") ($ millions)(1) |
271 |
284 |
529 |
562 |
|
|
Assets under management ("AUM") ($ billions)(1)(3) |
1,261 |
1,361 |
|||
|
Financial Strength |
Q2'22 |
Q2'21 |
|||
|
LICAT ratios (at period end)(4) |
|||||
|
|
128 % |
147 % |
|||
|
Sun Life Assurance(5) |
124 % |
125 % |
|||
|
Financial leverage ratio (at period end)(1) |
25.7 % |
24.7 % |
|||
|
_________________ |
|
|
(1) |
Represents a non-IFRS financial measure. For more details, see the Non-IFRS Financial Measures section in this document and in our MD&A for the period ended |
|
(2) |
All earnings per share ("EPS") measures refer to fully diluted EPS, unless otherwise stated. |
|
(3) |
AUM is comprised of General Funds and Segregated Funds on our Statements of Financial Position, and other third-party assets managed by the Company ("other AUM"). For more details, see the Non-IFRS Financial Measures section in this document and in our Q2'22 MD&A. |
|
(4) |
For further information on the Life Insurance Capital Adequacy Test ("LICAT"), see section E - Financial Strength in our Q2'22 MD&A. Our LICAT ratios are calculated in accordance with OSFI-mandated guideline, Life Insurance Capital Adequacy Test. |
|
(5) |
|
Financial and Operational Highlights - Quarterly Comparison (Q2 2022 vs. Q2 2021)
Our strategy is focused on key business segments, where we aim to be a leader in the markets in which we operate.
|
($ millions, unless otherwise noted) |
||||||||||||
|
Reported net income (loss) - |
Underlying |
Insurance |
Wealth sales and asset |
|||||||||
|
Q2'22 |
Q2'21 |
change |
Q2'22 |
Q2'21 |
change |
Q2'22 |
Q2'21 |
change |
Q2'22 |
Q2'21 |
change |
|
|
|
160 |
404 |
(60) % |
344 |
290 |
19 % |
218 |
196 |
11 % |
4,438 |
3,825 |
16 % |
|
|
213 |
157 |
36 % |
154 |
165 |
(7) % |
213 |
191 |
12 % |
— |
— |
— |
|
Asset Management |
296 |
221 |
34 % |
270 |
311 |
(13) % |
— |
— |
— |
49,640 |
47,164 |
5 % |
|
|
131 |
143 |
(8) % |
148 |
152 |
(3) % |
305 |
323 |
(6) % |
3,298 |
4,024 |
(18) % |
|
Corporate |
(15) |
(25) |
nm(2) |
(24) |
(35) |
nm(2) |
— |
— |
— |
— |
— |
— |
|
Total |
785 |
900 |
(13) % |
892 |
883 |
1 % |
736 |
710 |
4 % |
57,376 |
55,013 |
4 % |
|
(1) Represents a non-IFRS financial measure. See the Non-IFRS Financial Measures section in this document and in the Q2'22 MD&A. |
|
(2) Not meaningful. |
Reported net income of
We continue to innovate and provide Clients with wealth solutions that are tailored to their personal needs. This quarter, SLGI Asset Management announced the launch of the
Foreign exchange translation led to an increase of
On
This quarter, we released our 10th annual medical stop-loss research report on high-cost medical claims. As the largest independent stop-loss provider in the
|
______________________ |
|
|
(1) |
|
|
(2) |
Refer to section C - Profitability in the Q2'22 MD&A for more information about experience-related items and the Non-IFRS Financial Measures section in this document for a reconciliation between reported net income and underlying net income. |
|
(3) |
Defined contribution sales include retained business sales. |
|
(4) |
|
|
(5) |
For more details, see section F - Performance by Business Segment in the Q2'22 MD&A. |
|
(6) |
By membership. |
|
(7) |
For more details, see the Forward-looking Statements section in this document and in the Q2'22 MD&A. |
Asset Management: A global leader in both public and alternative asset classes through MFS and SLC Management
Asset Management reported net income of $296 million increased
Foreign exchange translation led to an increase of $10 million in reported net income and $9 million in underlying net income.
Asset Management ended Q2'22 with
In the second quarter of 2022, 98%, 71% and 49% of MFS'
Our Asset Management businesses built on their commitment to integrating climate strategies as we continue our sustainability journey. In
Foreign exchange translation led to a decline of
We continue to leverage Sun Life's global asset management capabilities and execute on our growth strategy through strategic partnerships. In
In
Corporate
Corporate reported net loss of
IFRS 17 Insurance Contracts ("IFRS 17") and IFRS 9 Financial Instruments ("IFRS 9") to be Adopted in 2023
For periods beginning on or after
The adoption of IFRS 17 and IFRS 9 has no material implication on our business strategies, however, upon transition at
- A net transfer of approximately
$4.5 billion from shareholders' equity, primarily driven by the establishment of the contractual service margin ("CSM") on the balance sheet, among other items. - As we restate the comparative year on an IFRS 17 basis, we expect a mid-single digit decrease in our 2022 underlying net income.
The CSM balance will qualify as Tier 1 available capital. On
|
______________________ |
|
|
(1) |
Represents a non-IFRS financial measure. For more details, see the Non-IFRS Financial Measures section in this document and in the Q2'22 MD&A. |
|
(2) |
Based on a trailing 12-month basis. |
|
(3) |
Approximately 92% of MFS' AUM balance as at |
|
(4) |
An international group of asset managers committed to supporting the goal of achieving net zero carbon emissions by 2050 or sooner. |
Our medium-term financial objectives following the adoption of IFRS 17 and 9 will be:
- Underlying EPS growth: 8-10%
- Underlying ROE: 18%+ (an increase from 16%+ prior to transition)
- Underlying Dividend payout ratio: 40-50%
We continue to assess the impact that the adoption of IFRS 17 and IFRS 9 will have on our Consolidated Financial Statements and estimates of the financial impacts are subject to change as we continue to assess the implications of adopting both standards. For additional details, refer to Note 2 in the Interim Consolidated Financial Statements.
Earnings Conference Call
The Company's Q2'22 financial results will be reviewed at a conference call on
|
Media Relations Contact: |
Investor Relations Contact: |
|
|
|
|
Director, Corporate Communications |
Vice-President, Head of Investor Relations and Capital Markets |
|
Tel: 226-751-2391 |
Tel: 416-979-6496 |
|
Non-IFRS Financial Measures |
||
|
We report certain financial information using non-IFRS financial measures, as we believe that these measures provide information that is useful to investors in understanding our performance and facilitate a comparison of our quarterly and full year results from period to period. These non-IFRS financial measures do not have any standardized meaning and may not be comparable with similar measures used by other companies. For certain non-IFRS financial measures, there are no directly comparable amounts under IFRS. These non-IFRS financial measures should not be viewed in isolation from or as alternatives to measures of financial performance determined in accordance with IFRS. Additional information concerning non-IFRS financial measures and, if applicable, reconciliations to the closest IFRS measures are available in Q2 2022 MD&A under the heading M - Non-IFRS Financial Measures, in our annual MD&A under the heading L - Non-IFRS Financial Measures and the Supplementary Financial Information packages that are available on www.sunlife.com under Investors – Financial results and reports. |
||
|
1. Underlying Net Income and Underlying EPS |
||
|
Underlying net income (loss) and financial measures based on underlying net income (loss), including underlying EPS or underlying loss per share, and underlying ROE, are non-IFRS financial measures. Underlying net income (loss) removes from reported net income (loss) the impacts of the following items in our results under IFRS and when removed assist in explaining our results from period to period: |
||
|
(a) |
market-related impacts that differ from our best estimate assumptions, which include: (i) impacts of returns in equity markets, net of hedging, for which our best estimate assumptions are approximately 2% per quarter. This also includes the impact of the basis risk inherent in our hedging program, which is the difference between the return on underlying funds of products that provide benefit guarantees and the return on the derivative assets used to hedge those benefit guarantees; (ii) the impacts of changes in interest rates in the reporting period and on the value of derivative instruments used in our hedging programs including changes in credit and swap spreads, and any changes to the assumed fixed income reinvestment rates in determining the actuarial liabilities; and (iii) the impacts of changes in the fair value of investment properties in the reporting period; |
|
|
(b) |
assumption changes and management actions, which include: (i) the impacts of revisions to the methods and assumptions used in determining our liabilities for insurance contracts and investment contracts; and (ii) the impacts on insurance contracts and investment contracts of actions taken by management in the current reporting period, referred to as management actions which include, for example, changes in the prices of in-force products, new or revised reinsurance on in-force business, and material changes to investment policies for assets supporting our liabilities; and |
|
|
(c) |
other adjustments: |
|
|
i) |
fair value adjustments on MFS' share-based payment awards that are settled with MFS' own shares and accounted for as liabilities and measured at fair value each reporting period until they are vested, exercised and repurchased - this adjustment enhances the comparability of MFS' results with publicly traded asset managers in |
|
|
ii) |
acquisition, integration and restructuring costs - this adjustment enhances comparability of our results from period to period, by removing the impacts of costs, including the unwinding of the discount for certain liabilities related to acquisitions, that are not ongoing in nature and are incurred with the intent to generate benefits in future periods; |
|
|
iii) |
certain hedges in |
|
|
iv) |
other items that are unusual or exceptional in nature. |
|
|
All factors discussed in this document that impact our underlying net income are also applicable to reported net income. All EPS measures in this document refer to fully diluted EPS, unless otherwise stated. As noted below, underlying EPS excludes the dilutive impacts of convertible instruments. |
||
|
The following table sets out the post-tax amounts that were excluded from our underlying net income (loss) and underlying EPS and provides a reconciliation to our reported net income (loss) and EPS based on IFRS. |
||
|
Reconciliations of Select Net Income Measures |
Quarterly results |
Year-to-date |
||
|
($ millions, unless otherwise noted) |
Q2'22 |
Q2'21 |
2022 |
2021 |
|
Reported net income - Common shareholders |
785 |
900 |
1,643 |
1,837 |
|
Market-related impacts |
||||
|
Equity market impacts |
||||
|
Impacts from equity market changes |
(169) |
95 |
(193) |
162 |
|
Basis risk impacts |
10 |
4 |
32 |
9 |
|
Equity market impacts |
(159) |
99 |
(161) |
171 |
|
Interest rate impacts(1) |
||||
|
Impacts of interest rate changes |
(93) |
(50) |
(150) |
111 |
|
Impacts of credit spread movements |
20 |
(10) |
60 |
(18) |
|
Impacts of swap spread movements |
5 |
24 |
(8) |
12 |
|
Interest rate impacts |
(68) |
(36) |
(98) |
105 |
|
Impacts of changes in the fair value of investment properties |
75 |
28 |
145 |
24 |
|
Less: Market-related impacts |
(152) |
91 |
(114) |
300 |
|
Less: Assumption changes and management actions |
— |
2 |
1 |
(2) |
|
Other adjustments |
||||
|
Fair value adjustments on MFS' share-based payment awards |
44 |
(52) |
41 |
(96) |
|
Acquisition, integration and restructuring(2)(3) |
(74) |
(13) |
(95) |
(87) |
|
Other(4)(5) |
75 |
(11) |
75 |
(11) |
|
Less: Total of other adjustments |
45 |
(76) |
21 |
(194) |
|
Underlying net income |
892 |
883 |
1,735 |
1,733 |
|
Reported EPS (diluted) ($) |
1.34 |
1.53 |
2.80 |
3.12 |
|
Less: Market-related impacts ($) |
(0.26) |
0.16 |
(0.20) |
0.50 |
|
Assumption changes and management actions ($) |
— |
— |
— |
— |
|
Fair value adjustments on MFS' share-based payment awards ($) |
0.08 |
(0.09) |
0.07 |
(0.16) |
|
Acquisition, integration and restructuring ($) |
(0.13) |
(0.02) |
(0.16) |
(0.15) |
|
Other ($) |
0.13 |
(0.02) |
0.13 |
(0.02) |
|
Impact of convertible securities on diluted EPS ($) |
— |
— |
(0.01) |
— |
|
Underlying EPS (diluted) ($) |
1.52 |
1.50 |
2.97 |
2.95 |
|
(1) |
Our exposure to interest rates varies by product type, line of business, and geography. Given the long-term nature of our business, we have a higher degree of sensitivity in respect of interest rates at long durations. |
|
(2) |
Amounts relate to acquisition costs for our SLC affiliates, BentallGreenOak, |
|
(3) |
The restructuring charge of $57 million in Q1'21 related to our strategy for our workspace and redefining the role of the office. |
|
(4) |
Relates to a Q2'22 gain on the sale-leaseback of our |
|
(5) |
Amounts relate to the |
|
The following table shows the pre-tax amount of underlying net income adjustments: |
|
Quarterly results |
Year-to-date |
|||
|
($ millions, unless otherwise noted) |
Q2'22 |
Q2'21 |
2022 |
2021 |
|
Reported net income - Common shareholders (after-tax) |
785 |
900 |
1,643 |
1,837 |
|
Underlying net income adjustments (pre-tax): |
||||
|
Less: Market-related impacts |
(109) |
85 |
84 |
465 |
|
Assumption changes and management actions |
— |
2 |
1 |
(4) |
|
Other adjustments(1) |
57 |
(64) |
31 |
(208) |
|
Total underlying net income adjustments (pre-tax) |
(52) |
23 |
116 |
253 |
|
Less: Taxes related to underlying net income adjustments(1) |
(55) |
(6) |
(208) |
(149) |
|
Underlying net income (after-tax) |
892 |
883 |
1,735 |
1,733 |
|
(1) |
Effective |
|
Taxes related to underlying net income adjustments may vary from the expected effective tax rate range reflecting the mix of business based on the Company's international operations. |
|
2. Additional Non-IFRS Financial Measures |
|
Assets under management. AUM is a non-IFRS financial measure that indicates the size of our company's asset management, wealth, and insurance assets. There is no standardized financial measure under IFRS. In addition to the most directly comparable IFRS measures, which are the balance of General funds and Segregated funds on our Statements of Financial Position, AUM also includes Other AUM. |
|
Other AUM is composed of retail, institutional and other-third party assets, as well as general fund and segregated fund assets managed by our joint ventures. In |
|
Effective |
|
Quarterly results |
||
|
($ millions) |
Q2'22 |
Q2'21 |
|
General fund assets |
195,382 |
195,689 |
|
Segregated funds |
120,098 |
133,249 |
|
Other AUM |
945,554 |
1,031,753 |
|
Total assets under management |
1,261,034 |
1,360,691 |
|
Assumption changes and management actions. In this document the impacts of ACMA on shareholders' net income (after-tax) is included in reported net income and is excluded from underlying net income, as described in section C - Profitability in the Q2'22 MD&A. |
|
Note 6.A of the Interim Consolidated Financial Statements for the period ended June 30, 2022 shows the pre-tax impacts of method and assumption changes on shareholders' and participating policyholders' insurance contract liabilities net of reinsurance assets, excluding changes in other policy liabilities and assets. The view in this document of ACMA is the impacts on shareholders' reported net income (after-tax). The Consolidated Financial Statements view is a component of the change in total company liabilities. |
|
The following table provides a reconciliation of the differences between the two measures. |
|
Quarterly results |
Year-to-date |
|||
|
($ millions) |
Q2'22 |
Q2'21 |
2022 |
2021 |
|
Impacts of method and assumption changes on insurance contract liabilities (pre-tax) |
— |
(26) |
5 |
(34) |
|
Less: Participating policyholders(1) |
— |
(26) |
4 |
(30) |
|
Impacts of method and assumption changes excluding participating policyholders (pre-tax) |
— |
— |
1 |
(4) |
|
Less: Tax |
— |
— |
— |
(2) |
|
Impacts of method and assumption changes excluding participating policyholders (after-tax) |
— |
— |
1 |
(2) |
|
Add: Management actions (after-tax)(2) |
— |
2 |
— |
— |
|
Other (after-tax)(3) |
— |
— |
— |
— |
|
Assumption changes and management actions (after-tax)(4)(5) |
— |
2 |
1 |
(2) |
|
(1) |
Adjustment to remove the pre-tax impacts of method and assumption changes on amounts attributed to participating policyholders. |
|
(2) |
Adjustment to include the after-tax impacts of management actions on insurance contract liabilities and investment contract liabilities which include, for example, changes in the prices of in-force products, new or revised reinsurance on in-force business, and material changes to investment policies for assets supporting our liabilities. The pre-tax impact of management actions to Method and assumption changes on insurance contract liabilities was $nil in Q2'22 and $nil for the first six months of 2022 (Q2'21 - an increase of |
|
(3) |
Adjustments to include the after-tax impacts of method and assumption changes on investment contracts and other policy liabilities, and the pre-tax impact to Method and assumption changes on insurance contract liabilities was $nil in Q2'22 and $nil for the first six months of 2022 (Q2'21 - $nil; the first six months of 2021 - $nil). |
|
(4) |
Includes the tax impacts of ACMA on insurance contract liabilities and investment contract liabilities, reflecting the tax rates in the jurisdictions in which we do business. |
|
(5) |
ACMA is included in reported net income and is excluded in calculating underlying net income, as described in section C - Profitability in the Q2'22 MD&A. |
|
Cash and other liquid assets. This measure is comprised of cash, cash equivalents, short-term investments, and publicly traded securities, net of loans related to acquisitions that are held at |
|
|
($ millions) |
As at |
As at |
|
Cash, cash equivalents & short-term securities |
580 |
2,383 |
|
Debt securities(1) |
1,428 |
1,421 |
|
Equity securities(2) |
98 |
861 |
|
Sub-total(3) |
2,106 |
4,665 |
|
Less: Loans related to acquisitions (held at |
(1,109) |
— |
|
Cash and other liquid assets (held at |
997 |
4,665 |
|
(1) |
Includes publicly traded bonds. |
|
(2) |
Includes ETF Investments. |
|
(3) |
Q4'21 amounts included |
|
(4) |
Loans related to acquisitions have been included as an adjustment to Cash and other liquid assets, as they reflect funding for the DentaQuest acquisition. |
|
(5) |
Represents available funds for capital re-deployment. |
|
3. Reconciliations of Select Non-IFRS Financial Measures |
|
|
Reported Net Income to Underlying Net Income Reconciliation - Pre-tax by |
|
|
Q2'22 |
|||||||||||||||
|
($ millions) |
Canada |
U.S. |
Asset Management |
|
Corporate |
Total |
|||||||||
|
Reported net income (loss) - Common shareholders |
160 |
213 |
296 |
131 |
(15) |
785 |
|||||||||
|
Less: Market-related impacts (pre-tax)(1) |
(143) |
43 |
— |
(12) |
3 |
(109) |
|||||||||
|
ACMA (pre-tax) |
— |
— |
— |
— |
— |
— |
|||||||||
|
Other adjustments (pre-tax)(1)(2) |
(1) |
32 |
32 |
(6) |
— |
57 |
|||||||||
|
Tax expense (benefit) on above items(2) |
(40) |
(16) |
(6) |
1 |
6 |
(55) |
|||||||||
|
Underlying net income (loss) |
344 |
154 |
270 |
148 |
(24) |
892 |
|||||||||
|
Q2'21 |
|||||||||||||||
|
Reported net income (loss) - Common shareholders |
404 |
157 |
221 |
143 |
(25) |
900 |
|||||||||
|
Less: Market-related impacts (pre-tax)(1) |
106 |
(7) |
— |
(11) |
(3) |
85 |
|||||||||
|
ACMA (pre-tax) |
— |
— |
— |
2 |
— |
2 |
|||||||||
|
Other adjustments (pre-tax)(1)(2) |
— |
(2) |
(70) |
— |
8 |
(64) |
|||||||||
|
Tax expense (benefit) on above items(2) |
8 |
1 |
(20) |
— |
5 |
(6) |
|||||||||
|
Underlying net income (loss) |
290 |
165 |
311 |
152 |
(35) |
883 |
|||||||||
|
(1) |
For a breakdown of this adjustment made to arrive at a non-IFRS financial measure, see the heading Underlying Net Income and Underlying EPS. |
|
(2) |
Effective |
Forward-looking Statements
From time to time, the Company makes written or oral forward-looking statements within the meaning of certain securities laws, including the "safe harbour" provisions of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements contained in this document include statements (i) relating to our strategies; (ii) relating to our growth initiatives and other business objectives; (iii) relating to our targets and commitments (including with respect to net zero emissions); (iv) relating to the plans we have implemented in response to the COVID-19 pandemic and related economic conditions and their impact on the Company, (v) that are predictive in nature or that depend upon or refer to future events or conditions, and (vi) that include words such as "achieve", "aim", "ambition", "anticipate", "aspiration", "assumption", "believe", "could", "estimate", "expect", "goal", "initiatives", "intend", "may", "objective", "outlook", "plan", "project", "seek", "should", "strategy", "strive", "target", "will", and similar expressions. Forward-looking statements include the information concerning our possible or assumed future results of operations. These statements represent our current expectations, estimates, and projections regarding future events and are not historical facts, and remain subject to change, particularly in light of the ongoing and developing COVID-19 pandemic and its impact on the global economy and its uncertain impact on our business.
Forward-looking statements are not a guarantee of future performance and involve risks and uncertainties that are difficult to predict. Future results and shareholder value may differ materially from those expressed in these forward-looking statements due to, among other factors, the impact of the COVID-19 pandemic and related economic conditions on our operations, liquidity, financial conditions or results and the matters set out in the Q2'22 MD&A under the headings C - Profitability - 5 - Income taxes, E - Financial Strength and H - Risk Management and in
Important risk factors that could cause our assumptions and estimates, and expectations and projections to be inaccurate and our actual results or events to differ materially from those expressed in or implied by the forward-looking statements contained in this document, are set out below. The realization of our forward-looking statements, essentially depends on our business performance which, in turn, is subject to many risks, which have been further heightened with the current COVID-19 pandemic given the uncertainty of its duration and impact. Factors that could cause actual results to differ materially from expectations include, but are not limited to: market risks - related to the performance of equity markets; changes or volatility in interest rates or credit spreads or swap spreads; real estate investments; and fluctuations in foreign currency exchange rates; insurance risks - related to policyholder behaviour; mortality experience, morbidity experience and longevity; product design and pricing; the impact of higher-than-expected future expenses; and the availability, cost and effectiveness of reinsurance; credit risks - related to issuers of securities held in our investment portfolio, debtors, structured securities, reinsurers, counterparties, other financial institutions and other entities; business and strategic risks - related to global economic and political conditions; the design and implementation of business strategies; changes in distribution channels or Client behaviour including risks relating to market conduct by intermediaries and agents; the impact of competition; the performance of our investments and investment portfolios managed for Clients such as segregated and mutual funds; shifts in investing trends and Client preference towards products that differ from our investment products and strategies; changes in the legal or regulatory environment, including capital requirements and tax laws; the environment, environmental laws and regulations; operational risks - related to breaches or failure of information system security and privacy, including cyber-attacks; our ability to attract and retain employees; legal, regulatory compliance and market conduct, including the impact of regulatory inquiries and investigations; the execution and integration of mergers, acquisitions, strategic investments and divestitures; our information technology infrastructure; a failure of information systems and Internet-enabled technology; dependence on third-party relationships, including outsourcing arrangements; business continuity; model errors; information management; liquidity risks - the possibility that we will not be able to fund all cash outflow commitments as they fall due; and other risks - COVID-19 matters, including the severity, duration and spread of COVID-19; its impact on the global economy, and its impact on Sun Life's business, financial condition and or results; risks associated with IFRS 17 Insurance Contracts and IFRS 9 Financial Instruments; our international operations, including our joint ventures; market conditions that affect our capital position or ability to raise capital; downgrades in financial strength or credit ratings; and tax matters, including estimates and judgements used in calculating taxes.
The Company does not undertake any obligation to update or revise its forward-looking statements to reflect events or circumstances after the date of this document or to reflect the occurrence of unanticipated events, except as required by law.
About Sun Life
Sun Life is a leading international financial services organization providing asset management, wealth, insurance and health solutions to individual and institutional Clients. Sun Life has operations in a number of markets worldwide, including
View original content to download multimedia:https://www.prnewswire.com/news-releases/sun-life-reports-second-quarter-2022-results-301599448.html
SOURCE


Allstate Accelerates Auto Insurance Rate Increases
Sun Life declares dividends on Common and Preferred Shares payable in Q3 2022
Advisor News
- How can more Americans achieve financial independence?
- Savers vs. spenders: How money management attitudes impact financial confidence
- Demonstrating the value of life insurance to Gen Z
- Poor money habits are a dealbreaker in a new relationship
- DC plan sponsors see opportunity in alternatives
More Advisor NewsAnnuity News
- CA judge certifies class action in teachers’ lawsuit over in-plan annuity fees
- Globe Life Inc. (NYSE: GL) Records 52-Week High Thursday Morning
- AM Best Managing Director Joins ‘Target Topics’ Podcast to Discuss State of Delegated Underwriting Authority Enterprises Market
- KBRA Assigns Rating to TruSpire Retirement Insurance Company
- Partial annuitization: How advisors can help clients balance income, growth
More Annuity NewsHealth/Employee Benefits News
- New Life Science Study Findings Recently Were Reported by Researchers at Johns Hopkins University Bloomberg School of Public Health (Formulary-Related Insurance Denials of Single-Source Branded Drugs in the United States): Life Science
- Trademark Application for “MEMORIAL HERMANN HEALTH PLAN MEDICARE ADVANTAGE PLANS HEALTH PLAN COMMERCIAL GROUPS” Filed by Memorial Hermann Health System: Memorial Hermann Health System
- Harrison: Rising health insurance exchange costs bad news for working poor in MS
- 94% of Americans say Congress must act on health care costs
- They harvest the nation’s food, but a new rule may strip them of health insurance
More Health/Employee Benefits NewsLife Insurance News
- How can more Americans achieve financial independence?
- AM Best Assigns Credit Ratings to MAAGAP Insurance Inc.
- Critical care riders: the living benefit more clients should understand
- Globe Life Inc. (NYSE: GL) Records 52-Week High Thursday Morning
- AM Best Upgrades Credit Ratings of Sagicor Financial Company Ltd. and Most of Its Subsidiaries
More Life Insurance News